GENE ONLINE|News &
Opinion
Blog

Oncology
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
PDS Buys IL-12 Targeting Therapy From Merck KGaA for $121 Million Biobucks
2023-01-04
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
AstraZeneca Expands Oncology Portfolio with $320 Million Neogene Acquisition
2022-11-29
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
FDA Drops New Oncology Development Guidelines
2022-10-18
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
ODAC Votes Against Oncopeptides’ and Spectrum’s New Oncology Drugs
2022-09-26
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
Genentech Bets $650 Million Biobucks on China’s Jemincare’s Prostate Cancer Prospect
2022-08-19
Sanofi Abandons SERD Candidate After Second Breast Cancer Clinical Trial Blow
2022-08-18
1 2 3 6
LATEST
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
2023-03-28
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC
2023-03-28
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
2023-03-27
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Scroll to Top